p21-activated kinase 1: PAK'ed with potential
Christy C. Ong(Gene Therapy Laboratory), Klaus P. Hoeflich(Pivot), Marcia Belvin(CytomX Therapeutics (United States)), Hartmut Koeppen, Peter M. Haverty, Adrian L. Harris(University of Oxford), Lori S. Friedman, Wei Zhou(Broad Institute), Adrian M. Jubb(Allogene Therapeutics (United States))
Cited by 53
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k